Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
43.70
-0.64 (-1.44%)
At close: Jan 21, 2026, 4:00 PM EST
43.93
+0.23 (0.52%)
After-hours: Jan 21, 2026, 7:55 PM EST
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $2.1 billion as of January 21, 2026.
Market Cap
2.10B
Enterprise Value
1.74B
1-Year Change
n/a
Ranking
Category
Stock Price
$43.70
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $2.10B, an increase of 206.88%. That is a compound annual growth rate of 217.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 2.13B | 7.02% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |